Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Abrams

Showing results (271-280 of 371) with videos related to

Pageof 38
Sort By:
The Journal of Clinical Investigation|November 6, 2018
An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasionJohn D Klement, Amy V Paschall, Priscilla S Redd, et al.
AIDS (London, England)|August 28, 2007
Risk of cancers during interrupted antiretroviral therapy in the SMART studyMichael J Silverberg, Jacqueline Neuhaus, Mark Bower, et al.
JCI Insight|February 8, 2019
IFN regulatory factor-8 expression in macrophages governs an antimetastatic programDanielle Yf Twum, Sean H Colligan, Nicholas C Hoffend, et al.
AIDS (London, England)|September 11, 2015
Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survivalChun Chao, Lanfang Xu, Michael J Silverberg, et al.
Blood|April 7, 2019
Inhibition of platelet GPVI induces intratumor hemorrhage and increases efficacy of chemotherapy in miceJulia Volz, Elmina Mammadova-Bach, Jesus Gil-Pulido, et al.
AIDS (London, England)|April 23, 2008
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infectionJason V Baker, Grace Peng, Joshua Rapkin, et al.
The New England Journal of Medicine|March 10, 1994
A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDSD I Abrams, A I Goldman, C Launer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999
A phase I vaccine trial with peptides reflecting ras oncogene mutations of solid tumorsS N Khleif, S I Abrams, J M Hamilton, et al.
Prehospital and Disaster Medicine|March 9, 1994
An analysis of prehospital mortality in an earthquake. Disaster Reanimatology Study GroupE A Pretto, D C Angus, J I Abrams, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseasesJason V Baker, Grace Peng, Joshua Rapkin, et al.
Pageof 38

Showing results (271-280 of 371) with videos related to

Sort By:
Pageof 38
The Journal of Clinical Investigation|November 6, 2018
An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasionJohn D Klement, Amy V Paschall, Priscilla S Redd, et al.
AIDS (London, England)|August 28, 2007
Risk of cancers during interrupted antiretroviral therapy in the SMART studyMichael J Silverberg, Jacqueline Neuhaus, Mark Bower, et al.
JCI Insight|February 8, 2019
IFN regulatory factor-8 expression in macrophages governs an antimetastatic programDanielle Yf Twum, Sean H Colligan, Nicholas C Hoffend, et al.
AIDS (London, England)|September 11, 2015
Stromal immune infiltration in HIV-related diffuse large B-cell lymphoma is associated with HIV disease history and patient survivalChun Chao, Lanfang Xu, Michael J Silverberg, et al.
Blood|April 7, 2019
Inhibition of platelet GPVI induces intratumor hemorrhage and increases efficacy of chemotherapy in miceJulia Volz, Elmina Mammadova-Bach, Jesus Gil-Pulido, et al.
AIDS (London, England)|April 23, 2008
CD4+ count and risk of non-AIDS diseases following initial treatment for HIV infectionJason V Baker, Grace Peng, Joshua Rapkin, et al.
The New England Journal of Medicine|March 10, 1994
A comparative trial of didanosine or zalcitabine after treatment with zidovudine in patients with human immunodeficiency virus infection. The Terry Beirn Community Programs for Clinical Research on AIDSD I Abrams, A I Goldman, C Launer, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|March 27, 1999
A phase I vaccine trial with peptides reflecting ras oncogene mutations of solid tumorsS N Khleif, S I Abrams, J M Hamilton, et al.
Prehospital and Disaster Medicine|March 9, 1994
An analysis of prehospital mortality in an earthquake. Disaster Reanimatology Study GroupE A Pretto, D C Angus, J I Abrams, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 23, 2008
Poor initial CD4+ recovery with antiretroviral therapy prolongs immune depletion and increases risk for AIDS and non-AIDS diseasesJason V Baker, Grace Peng, Joshua Rapkin, et al.
Pageof 38